Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

by Alexandre Sostelly, François Mercier
Published 2019-05-01

Therapeutically-induced stable disease in oncology early clinical trials.

by Francois Mercier, Georgina Meneses-Lorente, Paul Grimsey, Alex Phipps, Francesca Michielin
Published 2020-01-01

Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial

by Sandrine Micallef, Alexandre Sostelly, Jiawen Zhu, Paul G. Baverel, Francois Mercier
Published 2022-04-01

Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two‐stage approaches

by Mathilde Marchand, Antonio Gonçalves, François Mercier, Pascal Chanu, Jin Y. Jin, Jérémie Guedj, René Bruno
Published 2024-06-01

Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML

by Toshihiko Oki, Francois Mercier, Hiroki Kato, Yookyung Jung, Thomas O. McDonald, Joel A. Spencer, Michael C. Mazzola, Nick van Gastel, Charles P. Lin, Franziska Michor, Toshio Kitamura, David T. Scadden
Published 2021-01-01